Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,095 public trials 2,042 recruiting studies

Lymphoproliferative Disorders trial results

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Complesso Ospedaliero S. Giovanni Addolorata Roma, (RM), Italy
  • Azienda Ospedaliera - Nuovo Ospedale "Torrette" Ancona, Italy
  • USL 8 - Ospedale S.Donato Arezzo, Italy
  • Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli Piceno, Italy
View all 43 locations
Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • U.O.C. Ematologia e Terapia Cellulare - Ospedale "C. e G. Mazzoni" di Ascoli Piceno Ascoli Piceno, Italy
  • U.O.C di Ematologia P.O. "S.Giuseppe Moscati" - 2° piano Aversa, Italy
  • UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Bari, Italy
  • Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy
View all 47 locations
Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Studienzentrum Aschaffenburg Aschaffenburg, Germany
  • MVZ Onkologie gGmbH der Klinikum Mittelbaden gGmbH Baden-Baden, Germany
  • HELIOS Klinikum, Klinik für Hämatologie, Onkologie und Immunologie Berlin, Germany
  • Onkologisches MVZ Berlin Tegel Berlin, Germany
View all 68 locations
Conditions
Angiomyolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +26 more
Locations
  • Novartis Investigative Site Wuhan, Hubei, China
  • Novartis Investigative Site Shanghai, Shanghai Municipality, China
  • Novartis Investigative Site Chengdu, Sichuan, China
  • Novartis Investigative Site Beijing, China